The 2020-2021 Submission Cycle is now closed.
Applicants selected for the Finalist round will be notified by mid-February.
Finalist Presentations will take place on March 3.

Creating a stronger, more equitable New York by bridging promising translational research to marketplace and commercial success
The X-Seed Award was created by Deerfield as a result of the partnership announced in September 2019 between NYCEDC and Deerfield to develop the Cure life sciences campus, which is slated to open in January 2021. The 12-story vertical campus is bringing together innovators from academia, government, industry, and the not-for-profit sectors under one roof to advance human health and accelerate the fight against disease.

Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.

Leadership

James Flynn
Claire Pomeroy
Nancy Thornberry
Elise Wang
Joseph Pearlberg

News

Deerfield Launches a Novel Funding Mechanism, the X-Seed Award, to Support Early-Stage Life Sciences and Underrepresented Company Founders

Proposal Submission

Applicants interested in the XSeed Grant Award will complete an online Letter of Intent addressing: Novelty, Genetics and Biologic Rationale.

A one-page Non-Confidential Executive Summary outlining the specific aims of the project should be included with the Letter of Intent submission.

2020 – 2021 Key Research Focus – Infectious Disease

The 2020-2021 submission cycle will close on January 29, 2021 at 11:59 PM EST.

All information provided in the proposal submission is non-confidential.

To view more details about the application and/or submit a proposal, please click here.

Contact

* is required field.

Error sending form, please try again.